326 related articles for article (PubMed ID: 38113353)
1. Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities.
Baglini E; Poggetti V; Cavallini C; Petroni D; Forini F; Nicolini G; Barresi E; Salerno S; Costa B; Iozzo P; Neglia D; Menichetti L; Taliani S; Da Settimo F
J Med Chem; 2024 Jan; 67(1):17-37. PubMed ID: 38113353
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system.
El Chemali L; Akwa Y; Massaad-Massade L
Biochem J; 2022 Jul; 479(13):1455-1466. PubMed ID: 35819398
[TBL] [Abstract][Full Text] [Related]
3. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
Taliani S; Pugliesi I; Da Settimo F
Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondrial energy metabolism with TSPO ligands.
Gut P
Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690
[TBL] [Abstract][Full Text] [Related]
6. The Ligands of Translocator Protein: Design and Biological Properties.
Mokrov GV; Deeva OA; Gudasheva TA
Curr Pharm Des; 2021; 27(2):217-237. PubMed ID: 32881658
[TBL] [Abstract][Full Text] [Related]
7. Translocator protein as a promising target for novel anxiolytics.
Costa B; Da Pozzo E; Martini C
Curr Top Med Chem; 2012; 12(4):270-85. PubMed ID: 22204481
[TBL] [Abstract][Full Text] [Related]
8. Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain.
Liu J; Huang J; Zhang Z; Zhang R; Zhang Z; Liu Y; Ma B
Neural Plast; 2022; 2022():8057854. PubMed ID: 36071748
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.
Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH
Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)).
Šileikytė J; Blachly-Dyson E; Sewell R; Carpi A; Menabò R; Di Lisa F; Ricchelli F; Bernardi P; Forte M
J Biol Chem; 2014 May; 289(20):13769-81. PubMed ID: 24692541
[TBL] [Abstract][Full Text] [Related]
11. Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO.
Iacobazzi RM; Lopalco A; Cutrignelli A; Laquintana V; Lopedota A; Franco M; Denora N
ChemMedChem; 2017 Aug; 12(16):1261-1274. PubMed ID: 28771957
[TBL] [Abstract][Full Text] [Related]
12. Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.
Qi X; Xu J; Wang F; Xiao J
Oxid Med Cell Longev; 2012; 2012():162934. PubMed ID: 23251719
[TBL] [Abstract][Full Text] [Related]
13. Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Da Pozzo E; Giacomelli C; Barresi E; Costa B; Taliani S; Passetti Fda S; Martini C
Biochem Soc Trans; 2015 Aug; 43(4):559-65. PubMed ID: 26551693
[TBL] [Abstract][Full Text] [Related]
14. The changing landscape in translocator protein (TSPO) function.
Selvaraj V; Stocco DM
Trends Endocrinol Metab; 2015 Jul; 26(7):341-8. PubMed ID: 25801473
[TBL] [Abstract][Full Text] [Related]
15. The translocator protein (TSPO): a novel target for cancer chemotherapy.
Austin CJ; Kahlert J; Kassiou M; Rendina LM
Int J Biochem Cell Biol; 2013 Jul; 45(7):1212-6. PubMed ID: 23518318
[TBL] [Abstract][Full Text] [Related]
16. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial translocator protein (TSPO): From physiology to cardioprotection.
Morin D; Musman J; Pons S; Berdeaux A; Ghaleh B
Biochem Pharmacol; 2016 Apr; 105():1-13. PubMed ID: 26688086
[TBL] [Abstract][Full Text] [Related]
18. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.
Rupprecht R; Papadopoulos V; Rammes G; Baghai TC; Fan J; Akula N; Groyer G; Adams D; Schumacher M
Nat Rev Drug Discov; 2010 Dec; 9(12):971-88. PubMed ID: 21119734
[TBL] [Abstract][Full Text] [Related]
19. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.
Veenman L; Shandalov Y; Gavish M
J Bioenerg Biomembr; 2008 Jun; 40(3):199-205. PubMed ID: 18670869
[TBL] [Abstract][Full Text] [Related]
20. Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases.
Hector M; Langmann T; Wolf A
Prog Retin Eye Res; 2024 May; 100():101249. PubMed ID: 38430990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
